TY - JOUR
T1 - In vitro translation, post-translational processing and secretion of pulmonary surfactant protein B precursors
AU - O'Reilly, Michael A.
AU - Weaver, Timothy E.
AU - Pilot-Matias, Tami J.
AU - Sarin, Virender K.
AU - Gazdar, Adi F.
AU - Whitsett, Jeffrey A.
PY - 1989/5/10
Y1 - 1989/5/10
N2 - Surfactant proteolipid SP-B is a hydrophobic protein of Mr = 8000 identified in organic solvent extracts of pulmonary surfactant. Analysis of the human SP-B RNA predicts that the active surfactant peptide is derived by proteolysis of an Mr = 40 000 precursor. In the present work, characteristics of synthesis, secretion and processing of SP-B were demonstrated in a pulmonary adenocarcinoma cell line by immunoprecipitation of radiolabelled precursors. Treatment of cells with tunicamycin resulted in synthesis and secretion of unglycosylated proSP-B of Mr = 39 000. Immunoprecipitation of protein produced by in vitro translation of human lung poly(A)+ RNA detected an Mr = 40 000 protein; the size discrepancy is likely related to cleavage of a leader signal sequence. Endoglycosidase-H-sensitive precursors of Mr = 41 000-43 000, pI = 5.1-5.4 were the first isoforms detected within the cells, and were processed to endoglycosidase-H-resistant isoforms and secreted. Neuraminidase and endoglycosidase-F-sensitive forms of proSP-B were first detected in the media at 60 min as Mr = 42-46 000 isoforms with pI = 4.6-5.1. Proteolytically processed isoforms of proSP-B were detected primarily in the media and were generated by cleavage of an amino-terminal Mr = 16 000 peptide resulting in Mr = 27 000-33 000 isoforms (pH = 5.6-6.8). The Mr = 27 000-33 000 isoforms were sensitive to neuraminidase, resulting in isoforms with pH = 6.0-6.8. Digestion of the Mr = 27 000-33 000 peptide with endoglycosidase-F resulted in isoforms of Mr = 23 000, pH = 6.0-6.8. The endoglycosidase-F-resistant peptide of Mr = 16 000, pI = 4.2-4.4 was identified with an antiserum generated against synthetic peptides derived from the amino-terminal domain, as deduced from the SP-B DNA sequence. Further proteolytic processing of the Mr = 27 000-33 000 isoforms to the Mr = 8000 peptide detected in surfactant was not observed in this cell line. Thus, in the H441-4 cells (a cell line with morphologic features of Clara cells), SP-B is synthesized as a preprotein which undergoes cleavage of a signal sequence and addition of asparagine-linked carbohydrate; proSP-B is secreted by processes which are independent of glycosylation. SP-B peptides of Mr = 27 000-33 000 and Mr = 16 000, representing carboxy and amino-terminal domains, accumulate in the media.
AB - Surfactant proteolipid SP-B is a hydrophobic protein of Mr = 8000 identified in organic solvent extracts of pulmonary surfactant. Analysis of the human SP-B RNA predicts that the active surfactant peptide is derived by proteolysis of an Mr = 40 000 precursor. In the present work, characteristics of synthesis, secretion and processing of SP-B were demonstrated in a pulmonary adenocarcinoma cell line by immunoprecipitation of radiolabelled precursors. Treatment of cells with tunicamycin resulted in synthesis and secretion of unglycosylated proSP-B of Mr = 39 000. Immunoprecipitation of protein produced by in vitro translation of human lung poly(A)+ RNA detected an Mr = 40 000 protein; the size discrepancy is likely related to cleavage of a leader signal sequence. Endoglycosidase-H-sensitive precursors of Mr = 41 000-43 000, pI = 5.1-5.4 were the first isoforms detected within the cells, and were processed to endoglycosidase-H-resistant isoforms and secreted. Neuraminidase and endoglycosidase-F-sensitive forms of proSP-B were first detected in the media at 60 min as Mr = 42-46 000 isoforms with pI = 4.6-5.1. Proteolytically processed isoforms of proSP-B were detected primarily in the media and were generated by cleavage of an amino-terminal Mr = 16 000 peptide resulting in Mr = 27 000-33 000 isoforms (pH = 5.6-6.8). The Mr = 27 000-33 000 isoforms were sensitive to neuraminidase, resulting in isoforms with pH = 6.0-6.8. Digestion of the Mr = 27 000-33 000 peptide with endoglycosidase-F resulted in isoforms of Mr = 23 000, pH = 6.0-6.8. The endoglycosidase-F-resistant peptide of Mr = 16 000, pI = 4.2-4.4 was identified with an antiserum generated against synthetic peptides derived from the amino-terminal domain, as deduced from the SP-B DNA sequence. Further proteolytic processing of the Mr = 27 000-33 000 isoforms to the Mr = 8000 peptide detected in surfactant was not observed in this cell line. Thus, in the H441-4 cells (a cell line with morphologic features of Clara cells), SP-B is synthesized as a preprotein which undergoes cleavage of a signal sequence and addition of asparagine-linked carbohydrate; proSP-B is secreted by processes which are independent of glycosylation. SP-B peptides of Mr = 27 000-33 000 and Mr = 16 000, representing carboxy and amino-terminal domains, accumulate in the media.
KW - (Human adenocarcinoma cell line)
KW - In vitro translation
KW - Posttranslational processing
KW - Pulmonary surfactant
UR - http://www.scopus.com/inward/record.url?scp=0024550966&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024550966&partnerID=8YFLogxK
U2 - 10.1016/0167-4889(89)90201-2
DO - 10.1016/0167-4889(89)90201-2
M3 - Article
C2 - 2713400
AN - SCOPUS:0024550966
SN - 0167-4889
VL - 1011
SP - 140
EP - 148
JO - Biochimica et Biophysica Acta - Molecular Cell Research
JF - Biochimica et Biophysica Acta - Molecular Cell Research
IS - 2-3
ER -